Prepare for the Registered Respiratory Therapist CSE with comprehensive flashcards and multiple-choice questions, including hints and explanations. Ace your exam with confidence!

Multiple Choice

Which cardiac biomarker is most specific for myocardial injury?

When diagnosing myocardial injury, you want a marker that is specific to heart muscle damage. Troponin I and Troponin T fit this need best because they are highly cardiac-specific and are released into the blood only when cardiac myocytes are injured. Once released, troponin remains elevated for a relatively long period, which helps detect injury even if the patient presents later. Other biomarkers here don’t point as directly to myocardial injury. BNP is released in response to ventricular stretch and is used mainly to assess heart failure and volume status, not acute myocardial necrosis. CK-MB is an enzyme found in both cardiac and skeletal muscle, so it can rise from non-cardiac muscle injury or trauma, making it less specific for heart muscle damage than troponin. D-dimer reflects fibrin degradation and is used to evaluate thrombotic conditions; it does not indicate myocardial cell death. So, the most specific choice for myocardial injury is the troponin biomarker, with its cardiac-only origin and clear pattern of elevation after cardiac cell death.

When diagnosing myocardial injury, you want a marker that is specific to heart muscle damage. Troponin I and Troponin T fit this need best because they are highly cardiac-specific and are released into the blood only when cardiac myocytes are injured. Once released, troponin remains elevated for a relatively long period, which helps detect injury even if the patient presents later.

Other biomarkers here don’t point as directly to myocardial injury. BNP is released in response to ventricular stretch and is used mainly to assess heart failure and volume status, not acute myocardial necrosis. CK-MB is an enzyme found in both cardiac and skeletal muscle, so it can rise from non-cardiac muscle injury or trauma, making it less specific for heart muscle damage than troponin. D-dimer reflects fibrin degradation and is used to evaluate thrombotic conditions; it does not indicate myocardial cell death.

So, the most specific choice for myocardial injury is the troponin biomarker, with its cardiac-only origin and clear pattern of elevation after cardiac cell death.